Junji Watanabe Selected Research

Junji Watanabe Research Topics

Disease

6	Inflammation (Inflammations) 06/2010 - 10/2003
4	Atherosclerosis 01/2013 - 08/2007
3	Myocardial Infarction 10/2021 - 01/2012
3	ST Elevation Myocardial Infarction 06/2021 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2012 - 08/2007
2	Neuroinflammatory Diseases 01/2022 - 10/2021
2	Neointima 12/2017 - 01/2013
2	Thrombosis (Thrombus) 12/2017 - 01/2013
2	Rheumatoid Arthritis 06/2012 - 10/2009
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010 - 11/2007
2	Coronary Disease (Coronary Heart Disease) 07/2009 - 08/2007
2	Neoplasms (Cancer) 04/2009 - 05/2003
1	Atrial Fibrillation 01/2022
1	Bradycardia 01/2022
1	Cognitive Dysfunction 01/2022
1	Heart Failure 10/2021
1	AIDS-Related Complex (ARC) 10/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2021
1	Stroke (Strokes) 10/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021
1	Hemorrhage 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Anemia 01/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2012
1	Colic (Abdominal Cramps) 06/2010
1	Crohn Disease (Crohn's Disease) 06/2010
1	Hyperlipidemias (Hyperlipidemia) 07/2009
1	Dyslexia (Alexia) 08/2008
1	Colitis 11/2007
1	Breast Neoplasms (Breast Cancer) 05/2007
1	Liver Diseases (Liver Disease) 01/2007
1	Hepatitis B 01/2007
1	Ulcer 04/2006
1	Pneumonia (Pneumonitis) 10/2003
1	Asthma (Bronchial Asthma) 10/2003
1	Endotoxemia 08/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 06/2012 - 08/2007
3	dihydromyricetinIBA 01/2022 - 10/2021
3	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2012
3	LipidsIBA 12/2017 - 08/2007
3	HDL LipoproteinsIBA 06/2012 - 08/2007
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2010 - 11/2007
2	Hemoglobins (Hemoglobin)IBA 01/2015 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 06/2012 - 08/2007
2	Indicators and Reagents (Reagents)IBA 02/2012 - 01/2007
2	PolymersIBA 04/2009 - 01/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2007 - 08/2007
1	monomethylauristatin FIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	C-Type Lectins (C-Type Lectin)IBA 10/2021
1	ADP-ribosyl CyclaseIBA 10/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	MetalsIBA 01/2013
1	Complement System Proteins (Complement)IBA 06/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 06/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2010
1	Celecoxib (Celebrex)FDA Link 06/2010
1	Interleukin-10 (Interleukin 10)IBA 06/2010
1	CholatesIBA 06/2010
1	Peroxidase (Myeloperoxidase)IBA 06/2010
1	Prostaglandins EIBA 02/2010
1	ApolipoproteinsIBA 02/2010
1	Apolipoproteins E (ApoE)IBA 02/2010
1	EnzymesIBA 10/2009
1	HaptoglobinsIBA 07/2009
1	HemopexinIBA 07/2009
1	polymyxin B nonapeptideIBA 04/2009
1	Epidermal Growth Factor (EGF)IBA 04/2009
1	ErbB Receptors (EGF Receptor)IBA 04/2009
1	Biological ProductsIBA 08/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2007
1	Lipoproteins (Lipoprotein)IBA 08/2007
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2007
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2007
1	AntigensIBA 01/2007
1	SuspensionsIBA 04/2006
1	Immunoglobulin E (IgE)IBA 10/2003
1	OvalbuminIBA 10/2003
1	EndotoxinsIBA 10/2003
1	Immunoglobulin G (IgG)IBA 10/2003
1	LipopolysaccharidesIBA 10/2003
1	AntibodiesIBA 10/2003
1	LigandsIBA 08/2003
1	Antineoplastic Agents (Antineoplastics)IBA 05/2003

Therapy/Procedure

3	Percutaneous Coronary Intervention 06/2021 - 01/2012
2	Stents 12/2017 - 01/2013
1	Catheters 01/2022
1	Transcatheter Aortic Valve Replacement 10/2021
1	Patient Readmission 10/2021
1	Drug-Eluting Stents 12/2017
1	Therapeutics 04/2009
1	Oral Administration 04/2006